Nav29 is a free application that allows patients and doctors to speed up the rare disease diagnosis process. We apply artificial intelligence to help patients and professionals identify symptoms and predict accurate diagnoses.

TrialGPT is a proof of concept developed by Fundación 29, leveraging the potential of LLMs to simplify the search for available clinical trials. It analyzes medical reports and matches patients with relevant trials, making the process faster and more accessible for everyone.

GeneWise is a proof of concept developed by Fundación 29. It demonstrates how generative AI can explain genetic information in a clear and understandable way for patients and their families.

Medical data sharing for research. HealthData29 facilitates sharing health datasets with researchers for use in medical research in a simple and secure way. The initiative includes a guide to good practices in the sharing and processing of this data and has been awarded by the Spanish Data Protection Agency.

This experiment, carried out in collaboration with the prominent Spanish researcher Lluis Montoliu, focuses on the use of language models to facilitate access to relevant information. Through an innovative interface, users can interact directly with a book written by Lluis about rare diseases, allowing them to better understand the complexity of these conditions. This tool seeks to provide value and support to patients and caregivers in the management of rare diseases.

It is a tool designed to facilitate access and understanding of the signs and symptoms of rare diseases, based on the 'Guide to Signs and Symptoms of Suspected Rare Diseases' created by the Government of Extremadura. Using artificial intelligence technology, this tool allows users to navigate and interact with content, making the identification of symptoms and suspicion of these diseases more accessible and direct. It is essential for anyone involved in the care and management of rare diseases. , providing key resources to recognize conditions early.